Article Information
PubMed
Print ISSN
Online ISSN
History
- Received May 23, 2007
- Accepted June 18, 2007
- Published online August 23, 2007.
Article Versions
- Earlier version (June 19, 2007 - 07:25).
- You are viewing the most recent version of this article.
Copyright & Usage
The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Clint Mitchell,
- Peyman Kabolizadeh,
- John Ryan,
- John D. Roberts,
- Adly Yacoub,
- David T. Curiel,
- Paul B. Fisher,
- Michael P. Hagan,
- Nicholas P. Farrell,
- Steven Grant and
- Paul Dent
- Departments of Biochemistry (P.D., C.M.), Medicine (J.D.R., S.G.), Biology (J.R.), Radiation Oncology (M.P.H., A.Y.), and Chemistry (N.P.F., P.K.), Virginia Commonwealth University, Richmond, Virginia; Departments of Pathology, Neurosurgery, and Urology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, College of Physicians and Surgeons, New York, New York (P.B.F.); and Division of Human Gene Therapy, Departments of Medicine, Pathology, and Surgery, and the Gene Therapy Center, University of Alabama at Birmingham, Birmingham, Alabama (D.T.C.)
- Address correspondence to:
Dr. Paul Dent, Department of Biochemistry, 401 College Street, Massey Cancer Center, Room 2-108, BOX 980035, Virginia Commonwealth University, Richmond, VA 23298-0035. E-mail: pdent{at}vcu.edu
Statistics from Altmetric.com
Article usage
In this issue
Low-Dose BBR3610 Toxicity in Colon Cancer Cells Is p53-Independent and Enhanced by Inhibition of Epidermal Growth Factor Receptor (ERBB1)-Phosphatidyl Inositol 3 Kinase Signaling
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement